Newsletter | March 16, 2026

03.16.26 -- 7 Strategies For Combination Product Regulatory Success

SPONSOR

 

 

In this discussion of formulation, dose, and device alignment, expert panelists Rubi Burlage, Dominick DeGrazio, and John Higgins will join host Tom von Gunden in a discussion of key considerations that should guide your weighing of delivery options. Register for free thanks to BD Pharmaceutical Systems.

FEATURED EDITORIAL

7 Strategies For Combination Product Regulatory Success

In this article, Fran DeGrazio lays out best practices for biopharma executive leadership and non-technical managers to sustain regulatory momentum for their combination product development and commercialization. Fran points to cross-functional collaboration, quality management systems, regulatory documentation, and post-market surveillance as keys to drug delivery product success. 

 

Nanoparticle Delivery Strategies For Pulmonary Cancers

Solid lung tumors have a complex tumor microenvironment that creates barriers to drug delivery. Nanoparticle therapies can overcome these challenges.

INDUSTRY INSIGHTS

 

Patient Adherence with A Novel Dosage Form

A sprinkle formulation helps patients with tremors or dysphagia take medication more easily, improving adherence, comfort, and care through a novel, FDA-approved oral granule format.

 

Streamline Your Fill And Finish Process Of Ready-To-Use Cartridges

An optimized nest design for pre-fillable cartridges was designed using numerical simulation and data analytics to improve efficiency in pharmaceutical production.

 

Selecting A Prefillable Syringe System With Confidence

Discover an advancement in the prefillable syringe market, uniquely integrating the syringe barrel, plunger, and needle shield/tip cap into a fully harmonized, verified system from a single supplier.

 

How GLP-1s Are Redefining Injectable Care For Chronic Conditions

GLP‑1 therapies are changing injectable care and driving rapid progress in delivery and manufacturing. See how patient needs, emerging tech, and regulations are reshaping chronic treatment.

 

A Superior Alternative To Solid Dispersions

Cutting-edge nanotechnology is now emerging, able to address bioavailability challenges and deliver higher drug loads in more patient-friendly formats with fewer and smaller pills and easier regimens.

SOLUTIONS

A/L/P Assembly, Label And Packaging